Hikal Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
8,279
8,592
9,090
10,015
12,799
Cost of Goods Sold (COGS) incl. D&A
6,323
7,036
7,292
7,873
10,354
Gross Income
1,956
1,556
1,799
2,143
2,446
SG&A Expense
459
477
794
904
963
EBIT
1,489
1,071
1,003
-
1,458
Unusual Expense
179
-
-
-
-
Non Operating Income/Expense
341
115
139
45
111
Interest Expense
680
600
622
483
484
Pretax Income
981
598
532
803
1,115
Income Tax
342
193
120
125
343
Consolidated Net Income
639
404
412
677
772
Net Income
639
404
412
677
772
Net Income After Extraordinaries
639
404
412
677
772
Net Income Available to Common
639
404
412
677
772
EPS (Basic)
5.18
3.28
3.34
5.49
6.26
Basic Shares Outstanding
123
123
123
123
123
EPS (Diluted)
5.18
3.28
3.34
5.49
6.26
Diluted Shares Outstanding
123
123
123
123
123
EBITDA
2,040
1,713
1,676
1,906
2,314
Other Operating Expense
8
8
2
24
24
Non-Operating Interest Income
10
12
12
25
30

About Hikal

View Profile
Address
Great Eastern Chambers, 6 Floor
Mumbai Maharashtra 400614
India
Employees -
Website http://www.hikal.com
Updated 09/14/2018
Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. It operates through the Crop Protection and Pharmaceuticals segments. The Crop Protection segment involves in manufacturing of intermediates and active ingredients.